Journey Medical (DERM) Accounts Payables (2020 - 2026)

Journey Medical's Accounts Payables history runs 7 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• Quarterly Accounts Payables fell 43.06% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (down 43.06% YoY) and the FY2025 annual result came in at $8.9 million, down 44.85% from the prior year.
• Accounts Payables was $8.2 million for Q1 2026 at Journey Medical, down from $8.9 million in the prior quarter.
• Across five years, Accounts Payables topped out at $43.7 million in Q1 2023 and bottomed at $8.2 million in Q1 2026.
• A 5-year average of $21.7 million and a median of $16.0 million in 2024 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2023 — Accounts Payables jumped 61.94% — and 2024, when it sank 64.86%.
• Journey Medical's Accounts Payables stood at $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.0 million in 2024, then tumbled by 44.85% to $8.9 million in 2025, then fell by 7.33% to $8.2 million in 2026.
• Business Quant data shows DERM's Accounts Payables at $8.2 million in Q1 2026, $8.9 million in Q4 2025, and $11.6 million in Q3 2025.